Hjem › Burkitts lymfom › Texas › Lubbock
Burkitts lymfom kliniske forsøg i Lubbock, TX
3 studier for Burkitts lymfom søger deltagere på steder i og omkring Lubbock (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Covenant Children's Hospital, Lubbock
- UMC Cancer Center / UMC Health System, Lubbock
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- Covenant Children's Hospital, Lubbock
- UMC Cancer Center / UMC Health System, Lubbock
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- Covenant Children's Hospital, Lubbock
- UMC Cancer Center / UMC Health System, Lubbock
Burkitts lymfom forsøg i andre byer
- Houston, TX21 studier
- Milwaukee, WI16 studier
- Philadelphia, PA16 studier
- New York City, NY14 studier
- Chicago, IL14 studier
- Cincinnati, OH12 studier
- Atlanta, GA12 studier
- Seattle, WA11 studier
- Boston, MA10 studier
- Durham, NC10 studier
- Aurora, CO10 studier
- Los Angeles, CA10 studier
Andre studier i Lubbock
- Crohns sygdom10 studier
- Ulcerøs colitis9 studier
- Brystkræft6 studier
- Ikke-småcellet lungecancer4 studier
- Psoriasisartrit3 studier
- Slagtilfælde3 studier
- Overvægt3 studier
- Overvægt3 studier
- Inflammatorisk tarmsygdom3 studier
- Multipelt myelom3 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.